Tandem Diabetes Care (TNDM) Stock Analysis & Winston Score
Tandem Diabetes Care, Inc., a medical device company, designs, develops, and commercializes various products for people with insulin-dependent diabetes in the United States and internationally. The company's flagship product is the t:slim X2 insulin delivery system, a pump platform that comprises t:slim X2 pump, its 300-unit disposable insulin cartridge, and an infusion set. It also provides t:slim X2 insulin with Basal-IQ and control IQ technology; t:slim X2 with G5 Integration; and Tandem Devi
Winston Score: 18/100 — Weak
Weak fundamentals across most pillars.
- Quality: Mixed (8/30)
- Growth: Weak (1/20)
- Cash Flow: Weak (0/10)
- Stability: Weak (0/10)
- Valuation: Data not available (0/10)
- Ownership: Good (8/15)
Key Facts
Price: $17.08
Market Cap: $1.2B
Sector: Healthcare
Industry: Medical - Devices
Exchange: NASDAQ
